Lost Money on Rocket Companies, Inc.(RKT)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky
GlobeNewswire News Room· 2025-06-10 17:01
NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Rocket Companies, Inc. ("Rocket Companies" or the "Company") (NYSE: RKT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rocket Companies investors who were adversely affected by alleged securities fraud between March 29, 2021 and April 1, 2021. Follow the link below to get more information and be contacted by a member of our team: https://www.zlk.com/pslra-1/rocke ...
Scripps Howard Fund announces winners of 72nd Scripps Howard Journalism Awards
Prnewswire· 2025-06-10 17:00
Core Points - The 72nd Scripps Howard Journalism Awards highlight the significant contributions of journalism in addressing critical societal issues, including financial mismanagement and environmental crises [1][3] - The awards recognize excellence across various media platforms, with nearly 600 entries evaluated by a panel of veteran journalists [1][3] Prize Money and Awards - The Scripps Howard Fund will distribute $140,000 in prize money to the winning organizations and journalists, including the prestigious Impact Award [2] - The Impact Award is given to the entry deemed to have the greatest societal impact among the winners [2] Award Winners - Notable winners include: - Excellence in Audio Storytelling: KUOW Public Radio, The Seattle Times – "Lost Patients" [3] - Excellence in Business/Financial Reporting: The Boston Globe – "Spotlight coverage of Steward Health Care" [3] - Excellence in Environmental Reporting: The Guardian U.S. – "Marathon: The Huge U.S. Toxic Fire Shrouded in Secrecy" [3] - Impact Award: STAT – "Health Care's Colossus," which examined UnitedHealth's practices affecting millions [3][4] Educational Initiatives - Winners will participate in a program to present their work to journalism students, fostering networking and storytelling skills [5] - The Scripps Howard Fund also recognizes excellence in journalism education with awards for Teacher of the Year and Administrator of the Year [5]
Gray Media Names Shalayna Valencia as General Manager of KOSA in Odessa, Texas
Globenewswire· 2025-06-10 17:00
ATLANTA, June 10, 2025 (GLOBE NEWSWIRE) -- Gray Media, Inc. has named Shalayna Valencia as the next General Manager and Director of Sales for KOSA, the CBS affiliate in Odessa, Texas. Shalayna is a seasoned leader in the media and digital space, known for her creativity, strategic thinking, and commitment to team development. She began her career as an Account Executive at KWES in Midland/Odessa and has since held key leadership roles, including Market President at Townsquare Media and most recently, Di ...
Stantec Announces the Closing of $425 Million Senior Unsecured Notes Offering
Globenewswire· 2025-06-10 17:00
(All financial figures are expressed in Canadian dollars) EDMONTON, Alberta, June 10, 2025 (GLOBE NEWSWIRE) -- Stantec Inc. (“Stantec”) (TSX, NYSE: STN), a global leader in sustainable engineering, architecture and environmental consulting, announced the closing of its previously announced private placement offering (the "Offering") of $425 million aggregate principal amount of senior unsecured notes due June 10, 2032 (the "Notes"). The Notes bear an interest rate of 4.374% per annum and were priced at par. ...
Merck & Co., Inc. (MRK) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript
Seeking Alpha· 2025-06-10 16:56
Core Insights - Merck is undergoing a significant transformation with promising developments in its pipeline, including two important Phase III study readouts for enlicitide and FDA approval for clesrovimab, an RSV vaccine [4] - The company has nearly 20 new assets in its pipeline, with ongoing launches of WINREVAIR and others showing strong initial performance [5] Company Developments - Merck announced two key Phase III study results for enlicitide, an oral PCSK9 inhibitor, which yielded positive outcomes [4] - The FDA approved clesrovimab, marking a significant milestone for Merck's RSV vaccine efforts [4] - The company is poised for a series of data readouts and product launches in the near future, indicating a robust growth trajectory [4] Future Outlook - Merck is preparing for nearly 20 additional product launches over the next few years, which is expected to enhance its market position [5] - The ongoing launches of existing products are off to strong starts, contributing to the company's optimistic outlook [5]
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Vestis Corporation (VSTS) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm
GlobeNewswire News Room· 2025-06-10 16:56
ATLANTA, June 10, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Vestis Corporation (“Vestis” or the “Company”) (NYSE: VSTS). The lawsuit alleges that Defendants disseminated materially false and/or misleading statements and/or failed to disclose material adverse information concerning Vestis’ ability to grow its business. If you purchased shares of Vestis between May 2, 2024 and May 6, 2025, and experienced a significant loss on that investment, you are encouraged to dis ...
Paramount to slash 3.5% of US staff in latest round of cuts: ‘Hard, but necessary'
New York Post· 2025-06-10 16:54
Core Points - Paramount Global is laying off 3.5% of its US workforce as part of ongoing cost-cutting measures due to declining cable TV subscribers [1] - The company previously reduced its workforce by 15% last year as part of a $500 million cost-cutting plan [1] - Paramount ended 2024 with 18,600 employees worldwide [1] Company Strategy - Co-CEOs stated that the layoffs are necessary to streamline the organization and prioritize the streaming business amid industry-wide declines [2] - The executives emphasized the need to address the current operating environment to position Paramount for future success [2] Workforce Impact - The layoffs will primarily affect the US workforce, but there is potential for future cuts to the international workforce [3] Merger and Legal Issues - Paramount is awaiting regulatory approval for its $8.4 billion merger with Skydance Media, which is currently in limbo due to ongoing legal issues [3] - The company is involved in mediation talks regarding President Trump's $20 billion lawsuit related to CBS News' "60 Minutes" program [5][6] - The Federal Communications Commission is investigating the lawsuit, which could impact the merger approval process [5]
Time To Invest In Limoneira
Seeking Alpha· 2025-06-10 16:54
The Pioneer Of Seeking Alpha's BAD BEAT Investing, Quad 7 Capital is a team of 7 analysts with a wide range of experience sharing investment opportunities for nearly 12 years. They are best known for their February 2020 call to sell everything & go short, & have been on average 95% long 5% short since May 2020. The broader company has expertise in business, policy, economics, mathematics, game theory, & the sciences. They share both long & short trades & invest personally in equities they discuss within the ...
AT&T Inc. (T) Presents at Mizuho Technology Conference 2025 Transcript
Seeking Alpha· 2025-06-10 16:53
AT&T Inc. (NYSE:T) Mizuho Technology Conference 2025 June 10, 2025 8:15 AM ET Company Participants Pascal Desroches - Senior EVP & CFO Conference Call Participants Jennifer Murtaugh Fritzsche - Greenhill & Co., Inc. Jennifer Murtaugh Fritzsche [indiscernible] I think I found [indiscernible] safe harbor. It's the perfect way to start this conference. So many of the business panel we're going to hear about the next few days are really [indiscernible]. We'll get into that. But I think [indiscernible] the safe ...
Wells Fargo & Company (WFC) Presents at Morgan Stanley US Financials, Payments & CRE Conference Transcript
Seeking Alpha· 2025-06-10 16:50
Wells Fargo & Company (NYSE:WFC) Morgan Stanley US Financials, Payments & CRE Conference June 10, 2025 9:00 AM ET Company Participants Michael P. Santomassimo - Senior EVP & CFO Conference Call Participants Betsy Lynn Graseck - Morgan Stanley, Research Division Betsy Lynn Graseck I'm just going to read a Morgan Stanley disclosure. Should I read now? Can I read it now? Or do I have to wait? For important disclosures, please see Morgan Stanley research disclosure website at morganstanley.com/researchdisclosur ...